Immune Activation and Inflammation in People With Human Immunodeficiency Virus: Challenging Targets
- PMID: 31282534
- PMCID: PMC7184903
- DOI: 10.1093/infdis/jiz351
Immune Activation and Inflammation in People With Human Immunodeficiency Virus: Challenging Targets
Comment on
-
A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation.J Infect Dis. 2020 Apr 27;221(10):1598-1606. doi: 10.1093/infdis/jiz344. J Infect Dis. 2020. PMID: 31282542 Free PMC article. Clinical Trial.
References
-
- Schouten J, Wit FW, Stolte IG, et al. . AGEhIV Cohort Study Group Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis 2014; 59:1787–97. - PubMed
-
- Rasmussen LD, May MT, Kronborg G, et al. . Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study. Lancet HIV 2015; 2:e288–98. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
